William Rapeport
Plus aucun poste en cours
Historique de carrière de William Rapeport
Anciens postes connus de William Rapeport
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Pulmocide Ltd.
 Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 23/03/2007 | 19/12/2019 |
| Directeur Général | 23/03/2007 | 19/12/2019 | |
| Directeur Technique/Scientifique/R&D | 23/03/2007 | 19/12/2019 | |
| Fondateur | 23/03/2007 | 19/12/2019 | |
| GALAPAGOS NV | Directeur/Membre du Conseil | 06/07/2009 | 30/06/2010 |
| GSK PLC | Corporate Officer/Principal | - | - |
| Glaxo Wellcome Plc | Corporate Officer/Principal | 01/01/1996 | - |
| PFIZER, INC. | Corporate Officer/Principal | 01/01/1988 | - |
RespiVert Ltd.
 RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | 01/11/2006 | - |
| Directeur Général | 01/11/2006 | - | |
| Fondateur | 01/11/2006 | - |
Formation de William Rapeport
| University of Glasgow | Undergraduate Degree |
| University of Oxford | Undergraduate Degree |
Statistiques
Internationale
| Royaume-Uni | 7 |
| Belgique | 2 |
| Etats-Unis | 2 |
Opérationnelle
| Director/Board Member | 3 |
| Corporate Officer/Principal | 3 |
| Chief Executive Officer | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 3 |
| Distribution Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| GALAPAGOS NV | Health Technology |
| PFIZER, INC. | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
RespiVert Ltd.
RespiVert Ltd. Medical DistributorsDistribution Services RespiVert Ltd. operates as a small molecule drug discovery company. The firm develops small-molecule inhaled therapies for the treatment of chronic obstructive pulmonary disease (COPD), asthma, and cystic fibrosis. The company was founded by William Garth Rapeport, Peter Strong, Kazuhiro Ito, John Murray and Peter Barnes in 2007 and is headquartered in London, the United Kingdom. | Distribution Services |
Pulmocide Ltd.
Pulmocide Ltd. Pharmaceuticals: MajorHealth Technology Pulmocide Ltd. provides biopharmaceutical services. It develops inhaled medicines for viral and fungal infections of the respiratory tract. The company was founded by William Garth Rapeport, John Murray, Kazuhiro Ito, and Peter Strong on March 23, 2007 and is headquartered in London, the United Kingdom. | Health Technology |
| Glaxo Wellcome Plc | Health Technology |
- Bourse
- Insiders
- William Rapeport
- Expérience
